Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 2 (2005), Issue 11 (November)

1. Global analysis of host tissue gene expression in the invasive front of colorectal liver metastases.
   Int J Cancer, 118(1): 74-89. [Abstract] [Full-text]
2. Dextran sodium sulfate strongly promotes colorectal carcinogenesis in Apc(Min/+) mice: inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms.
   Int J Cancer, 118(1): 25-34. [Abstract] [Full-text]
3. Efficacy of the MMP inhibitor MMI270 against lung metastasis following removal of orthotopically transplanted human colon cancer in rat.
   Int J Cancer, 118(1): 215-21. [Abstract] [Full-text]
4. Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis.
   Int J Cancer, 118(1): 6-10. [Abstract] [Full-text]
5. MF tricyclic and sulindac retard tumor formation in an animal model.
   Int J Cancer, 118(1): 11-6. [Abstract] [Full-text]
6. Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer.
   Int J Cancer, 118(1): 115-22. [Abstract] [Full-text]
7. Prospective study of dietary acrylamide and risk of colorectal cancer among women.
   Int J Cancer, 118(1): 169-73. [Abstract] [Full-text]
8. History and molecular genetics of Lynch syndrome in family G: a century later.
   JAMA, 294(17): 2195-202. [Abstract] [Full-text]
9. The intrinsic mitochondrial membrane potential of colonic carcinoma cells is linked to the probability of tumor progression.
   Cancer Res, 65(21): 9861-7. [Abstract] [Full-text]
10. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.
    Cancer Res, 65(21): 9817-23. [Abstract] [Full-text]
11. Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers.
    Oncogene, 24(48): 7253-6. [Abstract] [Full-text]
12. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study.
    BMJ, 331(7524): 1047. [Abstract] [Full-text]
13. Claudins upregulation in human colorectal cancer.
    FEBS Lett, 579(27): 6179-85. [Abstract] [Full-text]
14. Upregulation and dephosphorylation of cofilin: modulation by CD44 variant isoform in human colon cancer cells.
    Exp Mol Pathol, 79(3): 187-93. [Abstract] [Full-text]
15. Detection and quantification of mutations in the plasma of patients with colorectal tumors.
    Proc Natl Acad Sci U S A, 102(45): 16368-73. [Abstract] [Full-text]
16. Association between colonic screening, subject characteristics, and stage of colorectal cancer.
    Am J Gastroenterol, 100(11): 2531-9. [Abstract] [Full-text]
17. Inappropriate colorectal cancer screening: findings and implications.
    Am J Gastroenterol, 100(11): 2526-30. [Abstract] [Full-text]
18. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Am J Gastroenterol, 100(11): 2519-25. [Abstract] [Full-text]
19. Hypermethylation of the prostacyclin synthase (PTGIS) promoter is a frequent event in colorectal cancer and associated with aneuploidy.
    Oncogene, 24(49): 7320-6. [Abstract] [Full-text]
20. Azoxymethane is a genetic background-dependent colorectal tumor initiator and promoter in mice: effects of dose, route, and diet.
    Toxicol Sci, 88(2): 340-5. [Abstract] [Full-text]
21. Sensitization to apoptosis underlies KrasD12-dependent oncolysis of murine C26 colorectal carcinoma cells by reovirus T3D.
    J Virol, 79(23): 14981-5. [Abstract] [Full-text]
22. Tumour matrilysin expression predicts metastatic potential of stage I (pT1) colon and rectal cancers.
    Gut, 54(12): 1751-8. [Abstract] [Full-text]
23. The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2.
    Gut, 54(12): 1741-50. [Abstract] [Full-text]
24. Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer.
    Gut, 54(12): 1733-40. [Abstract] [Full-text]
25. Birth size and colorectal cancer risk: a prospective population based study.
    Gut, 54(12): 1728-32. [Abstract] [Full-text]
26. Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining.
    J Pathol, 207(4): 385-95. [Abstract] [Full-text]
27. Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified.
    J Pathol, 207(4): 377-84. [Abstract] [Full-text]
28. Photodynamic therapy with WST09 (Tookad): quantitative studies in normal colon and transplanted tumours.
    Int J Cancer, 118(2): 477-82. [Abstract] [Full-text]
29. Glutathione S-transferase T1 polymorphisms are associated with outcome in colorectal cancer.
    Carcinogenesis, 26(12): 2157-63. [Abstract] [Full-text]
30. One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan.
    Carcinogenesis, 26(12): 2164-71. [Abstract] [Full-text]
31. Preferential amplification of AURKA 91A (Ile31) in familial colorectal cancers.
    Int J Cancer, 118(2): 505-8. [Abstract] [Full-text]
32. Nuclear factor kappaB is downregulated and correlates with p53 in the Min mouse mucosa during an accelerated tumor growth.
    Int J Cancer, 118(2): 279-83. [Abstract] [Full-text]
33. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
    Carcinogenesis, 26(12): 2078-85. [Abstract] [Full-text]
34. Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapy.
    J Clin Oncol, 23(33): 8453-60. [Abstract] [Full-text]
35. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.
    J Natl Cancer Inst, 97(22): 1688-94. [Abstract] [Full-text]
36. Diabetes mellitus and risk of colorectal cancer: a meta-analysis.
    J Natl Cancer Inst, 97(22): 1679-87. [Abstract] [Full-text]
37. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline.
    J Clin Oncol, 23(33): 8512-9. [Abstract] [Full-text]
38. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?
    J Clin Oncol, 23(33): 8490-9. [Abstract] [Full-text]
39. Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.
    Oncogene, 24(51): 7630-4. [Abstract] [Full-text]
40. Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches.
    J Clin Epidemiol, 58(12): 1241-51. [Abstract] [Full-text]
41. Myofiber degeneration/regeneration is induced in the cachectic ApcMin/+ mouse.
    J Appl Physiol, 99(6): 2379-87. [Abstract] [Full-text]
42. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal anti-inflammatory drug-activated gene-1.
    Mol Pharmacol, 68(6): 1782-92. [Abstract] [Full-text]
43. Gene transfer of the vascular endothelial growth factor receptor flt-1 suppresses pulmonary metastasis associated with lung growth.
    Am J Respir Cell Mol Biol, 33(6): 629-35. [Abstract] [Full-text]
44. Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer.
    Int J Radiat Oncol Biol Phys, 63(5): 1316-24. [Abstract] [Full-text]
45. Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer.
    Int J Radiat Oncol Biol Phys, 63(5): 1309-15. [Abstract] [Full-text]
46. Tumor vascularity evaluated by transrectal color Doppler US in predicting therapy outcome for low-lying rectal cancer.
    Int J Radiat Oncol Biol Phys, 63(5): 1304-8. [Abstract] [Full-text]
47. The future development of bevacizumab in colorectal cancer.
    Oncology, 69: 34-45. [Abstract] [Full-text]
48. Managing patients treated with bevacizumab combination therapy.
    Oncology, 69: 25-33. [Abstract] [Full-text]
49. Bevacizumab combined with standard fluoropyrimidine-based chemotherapy regimens to treat colorectal cancer.
    Oncology, 69: 17-24. [Abstract] [Full-text]
50. Colorectal polyps: detection with low-dose multi-detector row helical CT colonography versus two sequential colonoscopies.
    Radiology, 237(3): 927-37. [Abstract] [Full-text]
51. CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting.
    Radiology, 237(3): 893-904. [Abstract] [Full-text]
52. A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer.
    Br J Cancer, 93(11): 1236-43. [Abstract] [Full-text]
53. Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancer.
    Br J Cancer, 93(11): 1230-5. [Abstract] [Full-text]
54. CT colonography: where have we been and where are we going?
    Radiology, 237(3): 819-33. [Abstract] [Full-text]
55. Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer.
    Cancer Chemother Pharmacol, 57(1): 114-9. [Abstract] [Full-text]
56. Fucoxanthin induces cell cycle arrest at G0/G1 phase in human colon carcinoma cells through up-regulation of p21WAF1/Cip1.
    Biochim Biophys Acta, 1726(3): 328-35. [Abstract] [Full-text]
57. Breast cancer in an MSH2 gene mutation carrier.
    Hum Pathol, 36(12): 1322-6. [Abstract] [Full-text]
58. Correlation of spectral imaging and visual grading for the quantification of thymidylate synthase protein expression in rectal cancer.
    Hum Pathol, 36(12): 1302-8. [Abstract] [Full-text]
59. Molecular mechanisms of hepatic metastasis in colorectal cancer.
    J Surg Oncol, 92(4): 347-59. [Abstract] [Full-text]
60. Expression of angiogenic VEGF-A (soluble isoforms 121, 165) and lymphangiogenic VEGF-C in colorectal cancers with micro-satellite instability.
    J Surg Oncol, 92(4): 317-25. [Abstract] [Full-text]
61. Escherichia coli verotoxin 1 mediates apoptosis in human HCT116 colon cancer cells by inducing overexpression of the GADD family of genes and S phase arrest.
    FEBS Lett, 579(29): 6604-10. [Abstract] [Full-text]
62. Artepillin C in Brazilian propolis induces G(0)/G(1) arrest via stimulation of Cip1/p21 expression in human colon cancer cells.
    Mol Carcinog, 44(4): 293-9. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.